Radnet's Strategic Positioning in Digital Health and AI Market Drives Buy Rating
Sidoti Adjusts RadNet Price Target to $88 From $72, Maintains Buy Rating
RadNet Analyst Ratings
Truist Financial Maintains RadNet(RDNT.US) With Buy Rating, Announces Target Price $80
Truist Financial Sticks to Their Buy Rating for Radnet (RDNT)
RadNet Is Maintained at Buy by Jefferies
Jefferies Maintains RadNet(RDNT.US) With Buy Rating, Raises Target Price to $80
Analysts Offer Insights on Healthcare Companies: Bicycle Therapeutics (BCYC) and Radnet (RDNT)
Barclays Maintains RadNet(RDNT.US) With Buy Rating, Maintains Target Price $79
RadNet Analyst Ratings
Barclays Upgrades RadNet to Overweight, Raises Price Target to $79
Barclays Upgrades RadNet(RDNT.US) to Buy Rating, Raises Target Price to $79
Truist Financial Maintains RadNet(RDNT.US) With Buy Rating
Truist Financial Sticks to Its Buy Rating for Radnet (RDNT)
RadNet Price Target Raised to $57.00/Share From $51.00 by Barclays
Barclays Reaffirms Their Hold Rating on Radnet (RDNT)
RadNet Analyst Ratings
Truist Securities Maintains Buy on RadNet, Raises Price Target to $70
RadNet Analyst Ratings
Jefferies Adjusts Price Target on RadNet to $75 From $61, Maintains Buy Rating